343 related articles for article (PubMed ID: 29404583)
1. Differences in the Reponses to Apheresis Therapy of Patients With 3 Histopathologically Classified Immunopathological Patterns of Multiple Sclerosis.
Stork L; Ellenberger D; Beißbarth T; Friede T; Lucchinetti CF; Brück W; Metz I
JAMA Neurol; 2018 Apr; 75(4):428-435. PubMed ID: 29404583
[TBL] [Abstract][Full Text] [Related]
2. Magnetic Resonance Imaging Correlates of Multiple Sclerosis Immunopathological Patterns.
Metz I; Gavrilova RH; Weigand SD; Frischer JM; Popescu BF; Guo Y; Gloth M; Tobin WO; Zalewski NL; Lassmann H; Tillema JM; Erickson BJ; Parisi JE; Becker S; König FB; Brück W; Lucchinetti CF
Ann Neurol; 2021 Sep; 90(3):440-454. PubMed ID: 34231919
[TBL] [Abstract][Full Text] [Related]
3. Apheresis in treatment of acute inflammatory demyelinating disorders.
Mühlhausen J; Kitze B; Huppke P; Müller GA; Koziolek MJ
Atheroscler Suppl; 2015 May; 18():251-6. PubMed ID: 25936333
[TBL] [Abstract][Full Text] [Related]
4. Immunoadsorption or plasma exchange in steroid-refractory multiple sclerosis and neuromyelitis optica.
Lipphardt M; Mühlhausen J; Kitze B; Heigl F; Mauch E; Helms HJ; Müller GA; Koziolek MJ
J Clin Apher; 2019 Aug; 34(4):381-391. PubMed ID: 30698295
[TBL] [Abstract][Full Text] [Related]
5. Mitoxantrone: a review of its use in multiple sclerosis.
Scott LJ; Figgitt DP
CNS Drugs; 2004; 18(6):379-96. PubMed ID: 15089110
[TBL] [Abstract][Full Text] [Related]
6. Relation between humoral pathological changes in multiple sclerosis and response to therapeutic plasma exchange.
Keegan M; König F; McClelland R; Brück W; Morales Y; Bitsch A; Panitch H; Lassmann H; Weinshenker B; Rodriguez M; Parisi J; Lucchinetti CF
Lancet; 2005 Aug 13-19; 366(9485):579-82. PubMed ID: 16099294
[TBL] [Abstract][Full Text] [Related]
7. Plasma exchange for steroid-refractory relapses in multiple sclerosis: an observational, MRI pilot study.
Meca-Lallana JE; Hernández-Clares R; León-Hernández A; Genovés Aleixandre A; Cacho Pérez M; Martín-Fernández JJ
Clin Ther; 2013 Apr; 35(4):474-85. PubMed ID: 23541130
[TBL] [Abstract][Full Text] [Related]
8. Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination.
Lucchinetti C; Brück W; Parisi J; Scheithauer B; Rodriguez M; Lassmann H
Ann Neurol; 2000 Jun; 47(6):707-17. PubMed ID: 10852536
[TBL] [Abstract][Full Text] [Related]
9. Comparative immunopathogenesis of acute disseminated encephalomyelitis, neuromyelitis optica, and multiple sclerosis.
Wingerchuk DM; Lucchinetti CF
Curr Opin Neurol; 2007 Jun; 20(3):343-50. PubMed ID: 17495631
[TBL] [Abstract][Full Text] [Related]
10. Plasma exchange for acute attacks of CNS demyelination: Predictors of improvement at 6 months.
Llufriu S; Castillo J; Blanco Y; Ramió-Torrentà L; Río J; Vallès M; Lozano M; Castellà MD; Calabia J; Horga A; Graus F; Montalban X; Saiz A
Neurology; 2009 Sep; 73(12):949-53. PubMed ID: 19770470
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic apheresis in pediatric patients with acute CNS inflammatory demyelinating disease.
Koziolek M; Mühlhausen J; Friede T; Ellenberger D; Sigler M; Huppke B; Gärtner J; Müller GA; Huppke P
Blood Purif; 2013; 36(2):92-7. PubMed ID: 24021839
[TBL] [Abstract][Full Text] [Related]
12. MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 2: Epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcome.
Jarius S; Ruprecht K; Kleiter I; Borisow N; Asgari N; Pitarokoili K; Pache F; Stich O; Beume LA; Hümmert MW; Ringelstein M; Trebst C; Winkelmann A; Schwarz A; Buttmann M; Zimmermann H; Kuchling J; Franciotta D; Capobianco M; Siebert E; Lukas C; Korporal-Kuhnke M; Haas J; Fechner K; Brandt AU; Schanda K; Aktas O; Paul F; Reindl M; Wildemann B;
J Neuroinflammation; 2016 Sep; 13(1):280. PubMed ID: 27793206
[TBL] [Abstract][Full Text] [Related]
13. Patterns of disease activity in multiple sclerosis: clinical and magnetic resonance imaging study.
Thompson AJ; Kermode AG; MacManus DG; Kendall BE; Kingsley DP; Moseley IF; McDonald WI
BMJ; 1990 Mar; 300(6725):631-4. PubMed ID: 2138923
[TBL] [Abstract][Full Text] [Related]
14. Indication and implementation of lipidapheresis, rheopheresis, or immunoadsorption (lessons learnt from Germany's largest apheresis center).
Heigl F; Hettich R; Lotz N; Reeg H; Eder B; Steckholzer-Kroth K; Browatzki M; Harre K; Arendt R
Atheroscler Suppl; 2009 Dec; 10(5):137-41. PubMed ID: 20129393
[TBL] [Abstract][Full Text] [Related]
15. Distinct brain imaging characteristics of autoantibody-mediated CNS conditions and multiple sclerosis.
Jurynczyk M; Geraldes R; Probert F; Woodhall MR; Waters P; Tackley G; DeLuca G; Chandratre S; Leite MI; Vincent A; Palace J
Brain; 2017 Mar; 140(3):617-627. PubMed ID: 28364548
[TBL] [Abstract][Full Text] [Related]
16. Neuromyelitis optica lesions may inform multiple sclerosis heterogeneity debate.
Brück W; Popescu B; Lucchinetti CF; Markovic-Plese S; Gold R; Thal DR; Metz I
Ann Neurol; 2012 Sep; 72(3):385-94. PubMed ID: 23034911
[TBL] [Abstract][Full Text] [Related]
17. Immunoadsorption in steroid-refractory multiple sclerosis: clinical experience in 60 patients.
Heigl F; Hettich R; Arendt R; Durner J; Koehler J; Mauch E
Atheroscler Suppl; 2013 Jan; 14(1):167-73. PubMed ID: 23357160
[TBL] [Abstract][Full Text] [Related]
18. Homogeneity of active demyelinating lesions in established multiple sclerosis.
Breij EC; Brink BP; Veerhuis R; van den Berg C; Vloet R; Yan R; Dijkstra CD; van der Valk P; Bö L
Ann Neurol; 2008 Jan; 63(1):16-25. PubMed ID: 18232012
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of no evidence of disease activity in a 7-year longitudinal multiple sclerosis cohort.
Rotstein DL; Healy BC; Malik MT; Chitnis T; Weiner HL
JAMA Neurol; 2015 Feb; 72(2):152-8. PubMed ID: 25531931
[TBL] [Abstract][Full Text] [Related]
20. Screening for MOG-IgG and 27 other anti-glial and anti-neuronal autoantibodies in 'pattern II multiple sclerosis' and brain biopsy findings in a MOG-IgG-positive case.
Jarius S; Metz I; König FB; Ruprecht K; Reindl M; Paul F; Brück W; Wildemann B
Mult Scler; 2016 Oct; 22(12):1541-1549. PubMed ID: 26869529
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
